30.07.2010 • NewsCelaneseQ2 results

Celanese Posts Q2 Profit Surge, Boosts 2010 Forecast

Celanese Corp said on Thursday that second-quarter profit rose 50 percent as the improving economy continued to increase demand for its products, and the chemical maker raised its full-year outlook.
Net income rose to $160 million, or $1.01 per share, from $107 million, or 69 cents per share, a year earlier.
Excluding one-time items, the company posted profit of $1.12 per share.

Revenue at the Dallas-based company rose 22 percent to $1.52 billion. Analysts expected $1.46 billion.

Celanese boosted its 2010 adjusted earnings outlook to $1.40 per share above 2009 earnings, or $3.11. It had previously forecast annual profit would be $1.25 above last year's. Analysts expect $3.06.

During the quarter, the company had said its increasingly diverse product line would help increase 2010 earnings.

Company

Celanese

Brüningstr.
Frankfurt
Germany

Company contact







Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.